Health Tech Market Forecast for 2030: Size, Drivers, and Competitive Outlook
Global health tech is on track to cross $800 billion by 2030 as virtual care, AI diagnostics, and remote monitoring scale across payers and providers. This forecast examines segment growth, regulatory tailwinds, and the competitive posture of incumbents and startups shaping digital care.
2030 Projections: Health Tech’s Next $800 Billion Frontier
Analysts expect global health tech to crest past the $800 billion mark by 2030, powered by persistent demand for virtual care, digitized clinical workflows, and consumer-grade devices. The overall digital health market is projected to reach roughly $809.2 billion by 2030, according to Grand View Research, with telehealth continuing to capture a major share of incremental spend. Big platform players including Apple, Alphabet, and Amazon are deepening their healthcare footprints, betting on device-led engagement, data interoperability, and low-friction access to care.
Telehealth remains the headline growth engine. The global telehealth market is forecast to reach approximately $455 billion by 2030, per Grand View Research, as hybrid and remote-first models move from pandemic-era stopgaps to standard offerings. Meanwhile, AI-enabled clinical tools are approaching commercial scale; the AI in healthcare segment is set to surpass $100 billion before decade’s end, according to MarketsandMarkets, underpinning triage, imaging, and decision support across provider networks.
Revenue Mix and Segment Outlook to 2030
The 2030 revenue picture is increasingly multi-modal. Telehealth platforms—anchored by virtual urgent care and behavioral health—are expected to benefit from an expanding employer and payer footprint, with category leaders like Teladoc Health prioritizing longitudinal care, chronic disease management, and integration with on-prem clinical pathways. On the enterprise side, electronic health record ecosystems from Epic Systems and Oracle Health are layering AI co-pilots and ambient documentation to improve throughput and revenue cycle performance.
Hardware-led monitoring will remain another pillar of growth. Connected devices from Medtronic, Abbott, and Philips are proliferating in cardiology, diabetes, and post-acute care. Consumer-grade wearables—enabled by platforms from Apple and Alphabet—increasingly feed clinical-grade insights, making device-data pipelines central to patient stratification and risk adjustment in value-based contracts.
...